CRF Health Partners Innovative US Biotech with TrialMax eCOA Solution


Applied Clinical Trials

CRF Health, a provider of patient-centered eSource technology solutions for the life sciences industry, announced that its TrialMax Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.